119 related articles for article (PubMed ID: 6161689)
1. Treatment of advanced untreated Hodgkin's disease with SCAB--an alternative to MOPP.
Diggs CH; Wiernik PH; Sutherland JC
Cancer; 1981 Jan; 47(2):224-8. PubMed ID: 6161689
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin.
Levi JA; Wiernik PH; Diggs CH
Med Pediatr Oncol; 1977; 3(1):33-40. PubMed ID: 65727
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
Wiernik PH; Schiffer CA
J Cancer Res Clin Oncol; 1988; 114(1):105-7. PubMed ID: 2450876
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with doxorubicin and lomustine. Treatment of refractory Hodgkin's disease.
Williams SD; Einhorn LH
JAMA; 1977 Oct; 238(15):1659-61. PubMed ID: 578254
[TBL] [Abstract][Full Text] [Related]
5. A new combination chemotherapy for resistant Hodgkin disease.
Vinciguerra V; Coleman M; Jarowski CI; Degnan TJ; Silver RT
JAMA; 1977 Jan; 237(1):33-5. PubMed ID: 62854
[TBL] [Abstract][Full Text] [Related]
6. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Gobbi PG; Pieresca C; Federico M; Di Renzo N; Narni F; Iannitto E; Grignani G; Cavanna L; Avanzini P; Partesotti G
J Clin Oncol; 1993 Apr; 11(4):712-9. PubMed ID: 7683044
[TBL] [Abstract][Full Text] [Related]
7. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Rodgers RW; Gamble JF; Loh KK; Shullenberger CC
Cancer; 1980 Dec; 46(11):2349-55. PubMed ID: 6159961
[TBL] [Abstract][Full Text] [Related]
9. The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
Straus DJ; Myers J; Passe S; Young CW; Nisce LZ; Lee BJ; Koziner B; Arlin Z; Kempin S; Gee T; Clarkson BD
Cancer; 1980 Jul; 46(2):233-40. PubMed ID: 6155987
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
Kurnick JE; White M; Ware DE; Robinson WA
Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
[TBL] [Abstract][Full Text] [Related]
12. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
[TBL] [Abstract][Full Text] [Related]
13. Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer; 1983 Apr; 51(8):1348-52. PubMed ID: 6186356
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Longo DL; Duffey PL; DeVita VT; Wiernik PH; Hubbard SM; Phares JC; Bastian AW; Jaffe ES; Young RC
J Clin Oncol; 1991 Aug; 9(8):1409-20. PubMed ID: 1712836
[TBL] [Abstract][Full Text] [Related]
15. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Tsushita K; Utsumi M; Shimoyama M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Tannir N; Hagemeister F; Velasquez W; Cabanillas F
J Clin Oncol; 1983 Jul; 1(7):432-9. PubMed ID: 6199478
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Harker WG; Kushlan P; Rosenberg SA
Ann Intern Med; 1984 Oct; 101(4):440-6. PubMed ID: 6206757
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Canellos GP; Anderson JR; Propert KJ; Nissen N; Cooper MR; Henderson ES; Green MR; Gottlieb A; Peterson BA
N Engl J Med; 1992 Nov; 327(21):1478-84. PubMed ID: 1383821
[TBL] [Abstract][Full Text] [Related]
19. [Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma].
Abele R; Alberto P; Germano G; Obrecht JP; Wagenknecht L
Schweiz Med Wochenschr; 1976 Jul; 106(28):961-3. PubMed ID: 63145
[TBL] [Abstract][Full Text] [Related]
20. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]